UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 31, 2022
Accession Number:
0001193125-22-158552
Submission Type:
POS AM
CIK:
0001016169
Company Name:
ANTARES PHARMA, INC.
File Number:
333-158630